CO6210751A2 - Derivados de indolinona y procedimiento para su fabricacion - Google Patents

Derivados de indolinona y procedimiento para su fabricacion

Info

Publication number
CO6210751A2
CO6210751A2 CO10067260A CO10067260A CO6210751A2 CO 6210751 A2 CO6210751 A2 CO 6210751A2 CO 10067260 A CO10067260 A CO 10067260A CO 10067260 A CO10067260 A CO 10067260A CO 6210751 A2 CO6210751 A2 CO 6210751A2
Authority
CO
Colombia
Prior art keywords
represent
group
hydrogen atom
procedure
manufacturing
Prior art date
Application number
CO10067260A
Other languages
English (en)
Inventor
Joern Merten
Svenja Renner
Carsten Reichel
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40718253&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6210751(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of CO6210751A2 publication Critical patent/CO6210751A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heat Sensitive Colour Forming Recording (AREA)

Abstract

La presente invención se refiere a derivados de indolinona específicos, a saber, los compuestos de la fórmulaen la que R1 representa un átomo de hidrógeno o un grupo CI-CH2-CO, y R2 y R3 representan, cada uno, un átomo de hidrógeno, o R2 y R3, tomados conjuntamente, representan un grupo con la condición de que cuando R1 representa un átomo de hidrógeno, R2 y R3, tomados conjuntamente, representan un grupo y a un procedimiento para su fabricación. 1.- Un compuesto de la fórmulaen la que R1 representa un átomo de hidrógeno o un grupo Cl-CH2-CO, y R2 y R3 representan, cada uno, un átomo de hidrógeno, o R2 y R3, tomados conjuntamente, representan un grupo con la condición de que cuando R1 representa un átomo de hidrógeno, R2 y R3, tomados conjuntamente, representan un grupo 2.- Un compuesto de la fórmula3.- Un compuesto de la fórmula
CO10067260A 2007-12-03 2010-06-03 Derivados de indolinona y procedimiento para su fabricacion CO6210751A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07122123 2007-12-03

Publications (1)

Publication Number Publication Date
CO6210751A2 true CO6210751A2 (es) 2010-10-20

Family

ID=40718253

Family Applications (1)

Application Number Title Priority Date Filing Date
CO10067260A CO6210751A2 (es) 2007-12-03 2010-06-03 Derivados de indolinona y procedimiento para su fabricacion

Country Status (36)

Country Link
US (1) US8067617B2 (es)
EP (1) EP2229360B1 (es)
JP (2) JP5933924B2 (es)
KR (2) KR101676261B1 (es)
CN (1) CN101883755B (es)
AR (1) AR069531A1 (es)
AU (1) AU2008333287B2 (es)
BR (1) BRPI0819991B1 (es)
CA (1) CA2705490C (es)
CL (1) CL2008003599A1 (es)
CO (1) CO6210751A2 (es)
CY (1) CY1123333T1 (es)
DK (1) DK2229360T3 (es)
EA (1) EA016196B1 (es)
EC (1) ECSP10010195A (es)
ES (1) ES2818993T3 (es)
HK (1) HK1145682A1 (es)
HR (1) HRP20201480T1 (es)
HU (1) HUE051550T2 (es)
IL (1) IL205348A (es)
LT (1) LT2229360T (es)
MA (1) MA31989B1 (es)
MX (1) MX2010005557A (es)
MY (1) MY148574A (es)
NZ (1) NZ585798A (es)
PE (1) PE20091445A1 (es)
PL (1) PL2229360T3 (es)
PT (1) PT2229360T (es)
RS (1) RS60818B1 (es)
SI (1) SI2229360T1 (es)
TN (1) TN2010000248A1 (es)
TW (1) TWI432415B (es)
UA (1) UA97872C2 (es)
UY (1) UY31506A1 (es)
WO (1) WO2009071524A2 (es)
ZA (1) ZA201002723B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY31506A1 (es) * 2007-12-03 2009-08-03 Derivados de indolinona y procedimiento para su preparacion
US20170065529A1 (en) 2015-09-09 2017-03-09 Boehringer Ingelheim International Gmbh Pharmaceutical dosage form for immediate release of an indolinone derivative
WO2012068441A2 (en) 2010-11-19 2012-05-24 Ratiopharm Gmbh Intedanib salts and solid state forms thereof
CN103787949A (zh) * 2012-10-31 2014-05-14 韩冰 一类保护移植器官的化合物及其用途
US20140350022A1 (en) 2013-05-10 2014-11-27 Boehringer Ingelheim International Gmbh Efficacious treatment of NSCLC and predictive clinical marker of the responsiveness of a tumour to a treatment
AU2014296032A1 (en) 2013-07-31 2016-03-17 Windward Pharma, Inc. Aerosol tyrosine kinase inhibitor compounds and uses thereof
US20140342772A1 (en) * 2013-09-12 2014-11-20 Bandwidth.Com, Inc. Predictive Caching of IP Data
CN104262232B (zh) * 2014-09-09 2016-05-04 苏州明锐医药科技有限公司 尼泰达尼的制备方法
CN105712923A (zh) * 2014-12-03 2016-06-29 江苏先声药业有限公司 一种尼达尼布杂质及其制备方法与应用
WO2016178064A1 (en) 2015-05-06 2016-11-10 Suven Life Sciences Limited Polymorph of nintedanib ethanesulphonate, processes and intermediates thereof
CN105001143A (zh) * 2015-07-24 2015-10-28 南京正大天晴制药有限公司 一种制备高纯度乙磺酸尼达尼布的方法
WO2017077551A2 (en) 2015-11-03 2017-05-11 Mylan Laboratories Limited An amorphous nintedanib esylate and solid dispersion thereof
CN109415314A (zh) * 2016-05-19 2019-03-01 上海诚妙医药科技有限公司 尼达尼布的新晶型及其制备方法及其用途
CN106543069A (zh) * 2016-09-20 2017-03-29 北京万全德众医药生物技术有限公司 6‑甲氧基羰基‑2‑氧代二氢吲哚的制备
CN108610308A (zh) * 2016-12-09 2018-10-02 上海奥博生物医药技术有限公司 一锅法制备尼达尼布中间体的方法
CN106841495B (zh) * 2017-04-21 2018-05-11 常州佳德医药科技有限公司 乙磺酸尼达尼布中基因毒性杂质的高灵敏度分析方法
WO2019048974A1 (en) * 2017-09-06 2019-03-14 Glenmark Pharmaceuticals Limited PROCESS FOR PREPARING NINTEDANIB
CN111465594B (zh) 2017-11-17 2023-11-07 费米有限公司 已知作为制备尼达尼布中间体的2-吲哚满酮的合成
CN110746378B (zh) * 2018-12-03 2021-11-05 江苏豪森药业集团有限公司 一种胺基中间体的制备方法
CN111377845A (zh) * 2018-12-27 2020-07-07 江苏先声药业有限公司 3-(二甲氨基(苯基)亚甲基)-2-氧化吲哚-6-羧酸甲酯及其制备方法与应用
CN111662223B (zh) * 2019-03-08 2023-07-14 四川科伦药物研究院有限公司 二氢吲哚酮衍生物及其中间体的制备方法
WO2022029805A1 (en) * 2020-08-07 2022-02-10 Bdr Lifesciences Private Limited An improved highly efficient process for the prepration of nintedanib and pharmaceutically acceptable salt thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4876863A (es) * 1972-01-22 1973-10-16
US6469181B1 (en) 1995-01-30 2002-10-22 Catalytica, Inc. Process for preparing 2-oxindoles and N-hydroxy-2-oxindoles
GB9516943D0 (en) * 1995-08-18 1995-10-18 Cancer Soc Auckland Div Nz Inc Novel cyclopropylindoles and their secoprecursors,and their use as prodrugs
ATE243195T1 (de) 1998-09-25 2003-07-15 Boehringer Ingelheim Pharma Neue substituierte indolinone mit einer inhibierenden wirkung auf verschiedene kinasen und cyclin/cdk-komplexe
US7291641B2 (en) * 1999-10-11 2007-11-06 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
UA75054C2 (uk) * 1999-10-13 2006-03-15 Бьорінгер Інгельхайм Фарма Гмбх & Ко. Кг Заміщені в положенні 6 індолінони, їх одержання та їх застосування як лікарського засобу
DE10117204A1 (de) 2001-04-06 2002-10-10 Boehringer Ingelheim Pharma In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel
DE10233500A1 (de) * 2002-07-24 2004-02-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylen]-6-methoxycarbonyl-2-indolinon-Monoethansulfonat und dessen Verwendung als Arzneimittel
US7148249B2 (en) * 2002-09-12 2006-12-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments
EP2130829A4 (en) * 2006-11-06 2010-12-01 Theravalues Corp NEW HYDROXYINDOLE DERIVATIVE
NZ585799A (en) * 2007-12-03 2012-04-27 Boehringer Ingelheim Int Process for the manufacture of an indolinone derivative in particular 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone
UY31506A1 (es) * 2007-12-03 2009-08-03 Derivados de indolinona y procedimiento para su preparacion

Also Published As

Publication number Publication date
KR101676261B1 (ko) 2016-11-15
EP2229360A2 (en) 2010-09-22
AR069531A1 (es) 2010-01-27
LT2229360T (lt) 2020-10-12
AU2008333287B2 (en) 2013-12-19
PL2229360T3 (pl) 2020-12-14
AU2008333287A1 (en) 2009-06-11
MX2010005557A (es) 2010-06-01
JP2015071602A (ja) 2015-04-16
ECSP10010195A (es) 2010-07-30
ES2818993T3 (es) 2021-04-14
KR20100097129A (ko) 2010-09-02
UA97872C2 (ru) 2012-03-26
MY148574A (en) 2013-04-30
HK1145682A1 (en) 2011-04-29
UY31506A1 (es) 2009-08-03
CA2705490A1 (en) 2009-06-11
CN101883755B (zh) 2013-06-26
PT2229360T (pt) 2020-09-15
EP2229360B1 (en) 2020-07-01
TWI432415B (zh) 2014-04-01
CY1123333T1 (el) 2021-12-31
DK2229360T3 (da) 2020-09-28
CN101883755A (zh) 2010-11-10
JP2011505346A (ja) 2011-02-24
IL205348A (en) 2014-06-30
BRPI0819991A2 (pt) 2015-05-12
TN2010000248A1 (fr) 2011-11-11
WO2009071524A2 (en) 2009-06-11
JP5933924B2 (ja) 2016-06-15
EA016196B1 (ru) 2012-03-30
US8067617B2 (en) 2011-11-29
SI2229360T1 (sl) 2020-11-30
TW200930702A (en) 2009-07-16
IL205348A0 (en) 2010-12-30
KR20150116909A (ko) 2015-10-16
JP6044025B2 (ja) 2016-12-14
BRPI0819991B1 (pt) 2022-02-15
CL2008003599A1 (es) 2010-08-20
MA31989B1 (fr) 2011-01-03
EA201000883A1 (ru) 2010-12-30
KR101712810B1 (ko) 2017-03-07
PE20091445A1 (es) 2009-10-19
HUE051550T2 (hu) 2021-03-01
WO2009071524A3 (en) 2009-10-01
NZ585798A (en) 2011-06-30
CA2705490C (en) 2016-02-02
US20100311985A1 (en) 2010-12-09
HRP20201480T1 (hr) 2020-12-11
ZA201002723B (en) 2010-12-29
RS60818B1 (sr) 2020-10-30

Similar Documents

Publication Publication Date Title
CO6210751A2 (es) Derivados de indolinona y procedimiento para su fabricacion
UY29742A1 (es) Procedimiento para la preparación de betamimeticos
UA113643C2 (xx) N-цикліламіди як нематоциди
ECSP109922A (es) Compuestos de pirazol y su uso como inhibidores raf
CR10157A (es) Compuestos químicos
EA201000395A1 (ru) Фунгицидные производные 2-алкилтио-2-хинолинилоксиацетамида
MA32319B1 (fr) Derives de triazine utiles comme inhibiteurs de la kinase pi3 et de mtor
EA200702464A1 (ru) Способы получения фенольных 4-бифенилилазетидин-2-онов
EA201100875A1 (ru) Новые пиразол-4-n-алкоксикарбоксамиды в качестве микробиоцидов
ES2531324T3 (es) Intermedio para producir un derivado de gamma-aminoácido bicíclico
EA200901609A1 (ru) Амиды пиразолкарбоновой кислоты, применимые в качестве микробиоцидов
BRPI0816911A8 (pt) Processo para preparação de 4-aminobut-2-enolidas
EA201170132A1 (ru) 5-гетероциклилалкил-3-гидрокси-2-фенилциклопент-2-еноны в качестве гербицидов
EA201000269A1 (ru) Новые гербициды
ATE554066T1 (de) Entzündungshemmende substituierte cyclobutendionverbindungen
UY30009A1 (es) Compuestos benzoilpirazol y herbicidas que los contienen
UA106880C2 (uk) Нові гербіциди
AR081819A1 (es) Derivados de pirimidil-piperidinil-oxipiridinona, composiciones farmaceuticas que los contienen y uso de los mismos para tratar diabetes, dislipemias, obesidad y otras enfermedades
AR058253A1 (es) Procedimiento para la preparacion de ferri-succinilcaseina
CR10540A (es) Derivados ciclopropil amina
CR9565A (es) Derivados del 4,5-diarilpirrol, su preparacion y su aplicacion en terapeutica
CR20110111A (es) Composicion farmaceutica solida
EA200702428A1 (ru) Способы получения 4-бифенилилазетидин-2-онов
GT200600102A (es) Procedimiento para la preparacion de compuestos benzoxazol sustituidos
BRPI0907052B8 (pt) processo para a preparação de compostos

Legal Events

Date Code Title Description
FG Application granted